skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 87  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Material Type:
Article
Add to My Research

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

The Lancet (British edition), 2021-09, Vol.398 (10304), p.957-980 [Peer Reviewed Journal]

2021 World Health Organization ;Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;info:eu-repo/semantics/openAccess ;Attribution ;2021 World Health Organization 2021 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01330-1 ;PMID: 34450083

Full text available

2
Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment
Material Type:
Article
Add to My Research

Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment

The Lancet (British edition), 2021-08, Vol.398 (10302), p.772-785 [Peer Reviewed Journal]

2021 World Health Organization ;Copyright © 2021 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 World Health Organization 2021 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01112-0 ;PMID: 34454675

Full text available

3
Organ procurement and transplantation during the COVID-19 pandemic
Material Type:
Article
Add to My Research

Organ procurement and transplantation during the COVID-19 pandemic

The Lancet, 2020-05, Vol.395 (10237), p.e95-e96 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31040-0 ;PMID: 32407668

Digital Resources/Online E-Resources

4
Haemolytic uraemic syndrome
Material Type:
Article
Add to My Research

Haemolytic uraemic syndrome

The Lancet (British edition), 2017-08, Vol.390 (10095), p.681-696 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 12, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)30062-4 ;PMID: 28242109

Full text available

5
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

The Lancet (British edition), 2021-02, Vol.22 (2), p.198-211 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;ISSN: 0140-6736 ;EISSN: 1474-5488 ;EISSN: 1474-547X ;DOI: 10.1016/S1470-2045(20)30641-0 ;PMID: 33476593

Full text available

6
Temporary circulatory support for cardiogenic shock
Material Type:
Article
Add to My Research

Temporary circulatory support for cardiogenic shock

The Lancet (British edition), 2020-07, Vol.396 (10245), p.199-212 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31047-3

Full text available

7
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
Material Type:
Article
Add to My Research

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial

The Lancet (British edition), 2022-07, Vol.400 (10346), p.104-115 [Peer Reviewed Journal]

Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00537-2 ;PMID: 35810756

Full text available

8
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

The Lancet (British edition), 2023-01, Vol.401 (10371), p.105-117 [Peer Reviewed Journal]

2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02420-5 ;PMID: 36495879

Full text available

9
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
Material Type:
Article
Add to My Research

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

The Lancet (British edition), 2021-03, Vol.397 (10277), p.892-901 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00224-5 ;PMID: 33676628

Full text available

10
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Material Type:
Article
Add to My Research

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

The Lancet (British edition), 2019-04, Vol.393 (10179), p.1453-1464 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32111-1 ;PMID: 30765123

Full text available

11
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Material Type:
Article
Add to My Research

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

The Lancet (British edition), 2018-02, Vol.391 (10121), p.659-667 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 17, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)33108-2 ;PMID: 29241979

Full text available

12
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Material Type:
Article
Add to My Research

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

The Lancet (British edition), 2022-01, Vol.399 (10319), p.61-116 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01701-3 ;PMID: 34863359

Full text available

13
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
Material Type:
Article
Add to My Research

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

The Lancet (British edition), 2021-06, Vol.397 (10293), p.2476-2486 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00788-1 ;PMID: 34010611

Full text available

14
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
Material Type:
Article
Add to My Research

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

The Lancet (British edition), 2020-07, Vol.396 (10244), p.121-128 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30748-0 ;PMID: 32446323

Full text available

15
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
Material Type:
Article
Add to My Research

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

The Lancet (British edition), 2020-09, Vol.396 (10254), p.819-829 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31824-9 ;PMID: 32877652

Full text available

16
Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study
Material Type:
Article
Add to My Research

Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study

The Lancet (British edition), 2020-08, Vol.396 (10250), p.545-552 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30733-9 ;PMID: 32828186

Full text available

17
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants
Material Type:
Article
Add to My Research

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants

The Lancet (British edition), 2020-11, Vol.396 (10261), p.1511-1524 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;Attribution ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31859-6 ;PMID: 33160572

Full text available

18
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
Material Type:
Article
Add to My Research

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1531-1539 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 9, 2016 ;2016. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)00562-6 ;PMID: 26948433 ;CODEN: LANCAO

Full text available

19
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
Material Type:
Article
Add to My Research

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

The Lancet (British edition), 2023-01, Vol.401 (10370), p.25-37 [Peer Reviewed Journal]

2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)02302-9 ;PMID: 36493791

Full text available

20
Heart failure drug treatment
Material Type:
Article
Add to My Research

Heart failure drug treatment

The Lancet (British edition), 2019-03, Vol.393 (10175), p.1034-1044 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31808-7 ;PMID: 30860029

Full text available

Results 1 - 20 of 87  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait